text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "cd34+"

89 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "cd34+"

118 Documents found
  • A Non-Viral Method for Modifying and Expanding Primary T Cells
    Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • Developing Patient-specific Cell Therapy Manufacturing Processes
    Poster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.
  • Instructions - Poietics™ Immune Cell Systems
    Instructions For Proper Use
  • Cell List – Integrated Solutions for Primary Cells and Transfection
  • Validation of Th17 Cell Differentiation from Peripheral Blood
    Lonza White Paper
  • Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCs
    Protocol for DC and T Cell Assay from Matched PBMCs
  • Transfection Protocol for Human Monocytes - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of human Monocytes with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for Mouse T cells (BALB/c) - Nucleofector™ I/II/2b Device
    Instructions of use for transfection of mouse T cells (BALB/c) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Transfection Protocol for mT cells (C57BL/6) - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of mouse T cells (C57BL/6) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Expanded HUVECs for High-throughput Screening
    HUVECs are a good primary endothelial cell type for many in vitro studies and also for several high-throughput screening applications. Consequently, Lonza offers, HUVEC-XL. These cells are expanded to passage-3 from pooled P1-HUVECs and packaged at 10 million cells per ampoule.
  • First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat Cells
    High throughput transfection of siRNA libraries has become a valuable tool in target identifi cation and validation. However, such screenings have so far been constrained to mostly easy-totransfect adherent cell lines. Lonza’s 96-well Shuttle® System, based on the well-established Amaxa® Nucleofector® Technology, extends these approaches to primary and diffi cult-to-transfect cells.
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Webinar - Clonetics™ Cells in Pancreatic Cancer Research
    Lonza_Webinars_Webinar_-_Clonetics_Cells_in_Pancreatic_Cancer_Research_pdf.pdf
  • Instructions & Technical Info - Endothelial Cell Systems
    Technical Information and Instructions for Proper Use of Endothelial Cells
  • TechSheet - Lung Blood Microvascular Endothelial Cell Systems
    Technical information sheet for Clonetics™ Lung Blood Microvascular Endothelial Cells
  • The Cell and Gene Therapies Journey from Translation to Commercialization
    Download our comprehensive eBook on how to accelerate cell and gene therapy development, from translation to GMP production and commercialization.
  • TechSheet - Dermal Blood Microvascular Endothelial Cell Systems
    Technical information sheet for Clonetics™ Dermal Blood Microvascular Endothelial Cells
  • Case Study – Improving the Expansion of Patients' T Cells
    In this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
  • TechSheet - Normal Human Dendritic Cell System
    Technical Information Sheet for Poietics™ Normal Human Dendritic Cell System
  • TechSheet - Umbilical Vein Endothelial Cell Systems
    Technical information sheet for CloneticsTM HUVEC cells
  • 3
  • 4(current)
  • 5